Y Chromosome–Linked B and NK Cell Deficiency in Mice

There are no primary immunodeficiency diseases linked to the Y chromosome, because the Y chromosome does not contain any vital genes. We have established a novel mouse strain in which all males lack B and NK cells and have Peyer’s patch defects. By 10 wk of age, 100% of the males had evident immunodeficiencies. Mating these immunodeficient males with wild-type females on two different genetic backgrounds for several generations demonstrated that the immunodeficiency is linked to the Y chromosome and is inherited in a Mendelian fashion. Although multicolor fluorescence in situ hybridization analysis showed that the Y chromosome in the mutant male mice was one third shorter than that in wild-type males, exome sequencing did not identify any significant gene mutations. The precise molecular mechanisms are still unknown. Bone marrow chimeric analyses demonstrated that an intrinsic abnormality in bone marrow hematopoietic cells causes the B and NK cell defects. Interestingly, fetal liver cells transplanted from the mutant male mice reconstituted B and NK cells in lymphocyte-deficient Il2rg−/− recipient mice, whereas adult bone marrow transplants did not. Transducing the EBF gene, a master transcription factor for B cell development, into mutant hematopoietic progenitor cells rescued B cell but not NK cell development both in vitro and in vivo. These Y chromosome–linked immunodeficient mice, which have preferential B and NK cell defects, may be a useful model of lymphocyte development.

[1]  S. Jacobsen,et al.  Emergence of NK-cell progenitors and functionally competent NK-cell lineage subsets in the early mouse embryo. , 2012, Blood.

[2]  Lewis L. Lanier,et al.  NK cell development, homeostasis and function: parallels with CD8+ T cells , 2011, Nature Reviews Immunology.

[3]  C. Fanta,et al.  NK-cell and B-cell deficiency with a thymic mass. , 2011, The New England journal of medicine.

[4]  Rudolf Grosschedl,et al.  Transcription control of early B cell differentiation. , 2010, Current opinion in immunology.

[5]  M. Busslinger,et al.  STAT5 in B cell development and leukemia. , 2010, Current opinion in immunology.

[6]  D. Campana,et al.  Primary B cell immunodeficiencies: comparisons and contrasts. , 2009, Annual review of immunology.

[7]  S. Jacobsen,et al.  FLT3 ligand and not TSLP is the key regulator of IL-7-independent B-1 and B-2 B lymphopoiesis. , 2008, Blood.

[8]  P. Pandolfi,et al.  Co‐inhibitory roles for glucocorticoid‐induced TNF receptor in CD1d‐dependent natural killer T cells , 2008, European journal of immunology.

[9]  C. Paget,et al.  A Y Chromosome-Linked Factor Impairs NK T Development1 , 2007, The Journal of Immunology.

[10]  S. Nutt,et al.  The transcriptional regulation of B cell lineage commitment. , 2007, Immunity.

[11]  B. Kee,et al.  Mature natural killer cell and lymphoid tissue–inducing cell development requires Id2-mediated suppression of E protein activity , 2007, The Journal of experimental medicine.

[12]  M. Kondo,et al.  Developmental switch of mouse hematopoietic stem cells from fetal to adult type occurs in bone marrow after birth , 2006, Proceedings of the National Academy of Sciences.

[13]  A. Satterthwaite,et al.  Autoreactive B Cell Responses to RNA-Related Antigens Due to TLR7 Gene Duplication , 2006, Science.

[14]  M. Kondo,et al.  IL-7 receptor signaling is necessary for stage transition in adult B cell development through up-regulation of EBF , 2005, The Journal of experimental medicine.

[15]  J. D. Di Santo,et al.  Roles for Common Cytokine Receptor γ-Chain-Dependent Cytokines in the Generation, Differentiation, and Maturation of NK Cell Precursors and Peripheral NK Cells in Vivo1 , 2005, The Journal of Immunology.

[16]  M. Busslinger Transcriptional control of early B cell development. , 2004, Annual review of immunology.

[17]  I. Mårtensson,et al.  Complementary Signaling through flt3 and Interleukin-7 Receptor α Is Indispensable for Fetal and Adult B Cell Genesis , 2003, The Journal of experimental medicine.

[18]  C. Cotta,et al.  Enforced expression of EBF in hematopoietic stem cells restricts lymphopoiesis to the B cell lineage , 2003, The EMBO journal.

[19]  A. Cumano,et al.  Arrested B Lymphopoiesis and Persistence of Activated B Cells in Adult Interleukin 7−/− Mice , 2001, The Journal of experimental medicine.

[20]  P. Morrissey,et al.  Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice , 2000, The Journal of experimental medicine.

[21]  I. Puzanov,et al.  Differentiation of NK1.1+, Ly49+ NK cells from flt3+ multipotent marrow progenitor cells. , 1999, Journal of immunology.

[22]  T. Mak,et al.  Abnormal Development of Intestinal Intraepithelial Lymphocytes and Peripheral Natural Killer Cells in Mice Lacking the IL-2 Receptor β Chain , 1997, The Journal of experimental medicine.

[23]  A. Sharpe,et al.  Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. , 1996, Immunity.

[24]  R. Grosschedl,et al.  Failure of B-cell differentiation in mice lacking the transcription factor EBF , 1995, Nature.

[25]  H. Weintraub,et al.  The helix-loop-helix gene E2A is required for B cell formation , 1994, Cell.

[26]  Ian Krop,et al.  E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements , 1994, Cell.

[27]  M. Raff,et al.  Early production of intracellular IgM by B-lymphocyte precursors in mouse , 1976, Nature.

[28]  L. Lanier,et al.  Transcriptional control of natural killer cell development and function. , 2011, Advances in immunology.

[29]  J. Monroe,et al.  Fate decisions regulating bone marrow and peripheral B lymphocyte development. , 2007, Advances in immunology.

[30]  J. D. Di Santo Natural killer cell developmental pathways: a question of balance. , 2006, Annual review of immunology.

[31]  A. Cumano,et al.  Differentiation of B lymphocytes from hematopoietic stem cells. , 2004, Methods in molecular biology.

[32]  C. Murre,et al.  E protein function in lymphocyte development. , 2002, Annual review of immunology.

[33]  R. Hardy,et al.  B cell development pathways. , 2001, Annual review of immunology.

[34]  M. Conley,et al.  Molecular approaches to analysis of X-linked immunodeficiencies. , 1992, Annual review of immunology.